The finding comes on the heels of highly flawed Washington Post and Military Times (Army Times, Marine Corps Times, etc.) articles suggesting the tiny CDMRP is duplicative and is taking needed DoD funding from elsewhere.
For GWI, research funding is available through two sources, the U.S. Department of Veterans Affairs (VA) and the CDMRP. VA funding is restricted to VA employees. CDMRP funding is available to any qualified researchers, including in academia or the public or private sectors, through a highly competetive, peer-reviewed process that includes "consumer reviewers" at every stage of the review process. ("Consumer reviewers" are individuals who are personally affected by the disease or disorder being studied.)
The study found that pain relief was greater at the higher dosage. Dr. Golomb said her study used CoQ10 produced by Jarrow Formulas.
The treatment was targeted at, and appears to have positively impacted the mitochondrial dysfunction believed to be a resultant component of GWI. In 2010, the Institute of Medicine estimated that 250,000 of the 696,842 veterans of the 1991 Gulf War are affected by this chronic multi-symptom illness.
The CDMRP was first funded for GWI in FY2006, and Dr. Golomb's study was among that first group that was funded.
-Anthony Hardie, Madison, Wis.